Earth Science Tech (ETST) Depreciation & Amortization (CF) (2015 - 2026)
Earth Science Tech (ETST) posted Depreciation & Amortization (CF) of -$58355.0 for Q1 2026, down 147.91% on a QoQ basis from $121790.0 in Q4 2025, and down 7.57% year-over-year from -$63132.1 in Q1 2025.
Earth Science Tech (ETST) Depreciation & Amortization (CF) (2015 - 2026) Analysis & Trends
Earth Science Tech's Depreciation & Amortization (CF) history runs 10 years deep, the most recent figure standing at -$58355.0 for Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 7.57% year-over-year to -$58355.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $284396.0 (up 427.14% YoY) and the FY2026 annual result came in at $284396.0, up 427.14% from the prior year.
- Depreciation & Amortization (CF) was -$58355.0 for Q1 2026 at Earth Science Tech, down from $121790.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $186398.0 in Q3 2025 and bottomed at -$58355.0 in Q1 2026.
- A 4-year average of $40674.7 and a median of $36127.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Peak annual rise in Depreciation & Amortization (CF) reached 461.59% in 2025, while the deepest fall reached 243.93% in 2025.
- Earth Science Tech's Depreciation & Amortization (CF) stood at $47965.0 in 2023, then fell by 6.64% to $44778.0 in 2024, then jumped by 171.99% to $121790.0 in 2025, then slumped by 147.91% to -$58355.0 in 2026.
- Business Quant data shows ETST's Depreciation & Amortization (CF) at -$58355.0 in Q1 2026, $121790.0 in Q4 2025, and $186398.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 239.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.04 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 22.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 676.10 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 172.00 Mn |
| 10 | Earth Science Tech | 41.03 Mn | 38.90 Mn | 6.27 Mn | -58,355.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58,355.00 |
| Mar 31, 2026 | -58,355.00 |
| Dec 31, 2025 | 121,790.00 |
| Dec 31, 2025 | 121,790.00 |
| Sep 30, 2025 | 186,398.00 |
| Sep 30, 2025 | 186,398.00 |
| Jun 30, 2025 | 34,563.00 |
| Jun 30, 2025 | 34,563.00 |
| Mar 31, 2025 | -54,250.00 |
| Mar 31, 2025 | -54,250.00 |
| Dec 31, 2024 | 44,778.00 |
| Dec 31, 2024 | 44,778.00 |
| Sep 30, 2024 | 33,191.00 |
| Sep 30, 2024 | 33,191.00 |
| Jun 30, 2024 | 30,232.00 |
| Jun 30, 2024 | 30,232.00 |
| Mar 31, 2024 | 37,691.00 |
| Mar 31, 2024 | 37,691.00 |
| Dec 31, 2023 | 47,965.00 |
| Dec 31, 2023 | 47,965.00 |